Either MicroStrategy’s Michael Saylor is a visionary, or he’s a delusional egomaniac,” Forbes observed in 1998, during the ...
The moment Bitcoiners around the world have been waiting for is finally here: Bitcoin has hit the monumental $100,000 mark, and Michael Saylor is throwing the Party of the Century to celebrate! What ...
A top crypto strategist says money invested in Bitcoin (BTC) is unlikely to rotate into the altcoin market at levels seen in ...
Why Michael Saylor’s MicroStrategy is a brilliant blueprint for manipulating traditional finance to harness the pixie dust of crypto mania.
And a new administration is coming in — and they love Bitcoin. Donald Trump is not even officially in office yet, and his family is already inviting Michael Saylor to his estate in Mar-a-Lago to ...
MicroStrategy co-founder Michael Saylor posted the Bitcoin (BTC) tracker for the 10th consecutive week on Jan. 12. The chart has come to signal an impending Bitcoin purchase and is typically ...
In a X Space, Bitcoin evangelist Michael Saylor laid out three game-changing catalysts that he believes will push Bitcoin not just to $500,000 but all the way to an eye-popping $5 million per coin.
The Michael Saylor-led firm has been buying Bitcoins for ten weeks in a row, and based on his most recent X post, MicroStrategy seems to be planning to buy more on Monday, coinciding with Trump ...
Michael Saylor’s tweet about Bitcoin being "on the menu" at Mar-a-Lago has set the crypto community abuzz. Eric Trump reinforces the sentiment by highlighting his shared enthusiasm for Bitcoin ...
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Prominent Bitcoin advocate Michael Saylor has met with Eric Trump, sharing a photo of the two ...
In this engaging discussion with host Michael Spector, Mr. Chia delves into CBL's mission to provide comprehensive one-stop ...
Kennedy Would Keep Legal Fees From Merck Cases if Confirmed By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. would retain legal fees earned from litigation against drugmaker Merck ...